Brainstorm Cell Therapeutics Inc (BCLI)
NASDAQ
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | -4.92M | -5.15M | -5.45M | -6.04M | -4.8M | -2.47M | -2.98M | -3.05M |
Pre Tax Income | -5.02M | -5.06M | -5.33M | -1.23M | -5.58M | -3.4M | -2.54M | -2.71M |
Net Income | -5.02M | -5.06M | -5.33M | -1.23M | -5.58M | -3.4M | -2.54M | -2.71M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -4.92M | -5.15M | -5.45M | -6.04M | -4.8M | -2.47M | -2.98M | -3.05M |
EBITDA | -4.85M | -5.08M | -5.38M | -5.97M | -4.74M | -2.41M | -2.92M | -2.99M |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | -5.08M | -5M | -14.06M | -23M | -31.68M | -24.54M | -24.82M | -21.44M |
Pre Tax Income | -4.98M | -4.95M | -13.95M | -23.25M | -31.81M | -24.46M | -24.28M | -17.19M |
Net Income | -4.98M | -4.95M | -13.95M | -23.25M | -31.81M | -24.46M | -24.28M | -17.19M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -0.267 | -0.261 | -0.672 | -1.003 | -0.905 | -0.672 | -0.662 | -0.351 |
EBIT | -5.08M | -5M | -14.06M | -23M | -31.68M | -24.54M | -24.82M | -21.44M |
EBITDA | -5.01M | -4.91M | -13.95M | -22.84M | -31.47M | -24.28M | -24.54M | -21.17M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.